Zobrazeno 1 - 10
of 53
pro vyhledávání: '"PF Gherardini"'
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Understanding how RNAs interact with proteins, RNAs, or other molecules remains a challenge of main interest in biology, given the importance of these complexes in both normal and pathological cellular processes. Since experimental datasets are start
Externí odkaz:
https://doaj.org/article/fc904e44499e4fdf8f2403b40ce418ba
Autor:
Till JE; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., McDaniel L; Personalis, Inc., Menlo Park, CA, USA., Chang C; Indiana University School of Medicine, Indianapolis, IN, USA., Long Q; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Da Silva DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Abbott C; Personalis, Inc., Menlo Park, CA, USA., Chen RO; Personalis, Inc., Menlo Park, CA, USA., Boyle SM; Personalis, Inc., Menlo Park, CA, USA., Bhagwat N; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Cannas S; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Sagreiya H; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Li W; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Yee SS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Abdalla A; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Wang Z; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Yin M; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Ballinger D; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Wissel P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Eads J; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Karasic T; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Schneider C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., O'Dwyer P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Teitelbaum U; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Reiss KA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Rahma OE; Dana-Farber Cancer Institute, Boston, MA, USA., Fisher GA; Stanford University, Stanford, CA, USA., Ko AH; University of California, San Francisco, San Francisco, CA, USA., Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA., Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Carpenter EL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. erical@upenn.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 09; Vol. 15 (1), pp. 5763. Date of Electronic Publication: 2024 Jul 09.
Autor:
Ballesio F; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Pepe G; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Ausiello G; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Novelletto A; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Helmer-Citterich M; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Gherardini PF; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Publikováno v:
Non-coding RNA research [Noncoding RNA Res] 2024 Jun 22; Vol. 9 (4), pp. 1257-1270. Date of Electronic Publication: 2024 Jun 22 (Print Publication: 2024).
Autor:
Pepe G; Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy., Appierdo R; Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy.; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy., Ausiello G; Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy., Helmer-Citterich M; Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy., Gherardini PF; Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 11; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 11.
Autor:
Pepe G; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Appierdo R; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Carrino C; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Ballesio F; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Helmer-Citterich M; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Gherardini PF; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Publikováno v:
Frontiers in molecular biosciences [Front Mol Biosci] 2022 Oct 07; Vol. 9, pp. 1000205. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).
Autor:
Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. lpadron@parkerici.org., Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA., Ko AH; University of California, San Francisco, San Francisco, CA, USA., Fisher G; Stanford University, Stanford, CA, USA., Rahma O; Dana-Farber Cancer Institute, Boston, MA, USA., Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Spasic M; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Xu J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Karakunnel J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Mick R; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Alanio C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Byrne KT; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA., Hollmann TJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Moore JS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Jones DD; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Tognetti M; Biognosys AG, Schlieren, Switzerland., Chen RO; Personalis, Inc., Menlo Park, CA, USA., Yang X; Apexigen, Inc., San Carlos, CA, USA., Salvador L; Bristol Myers Squibb, New York, NY, USA., Wherry EJ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Dugan U; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., O'Donnell-Tormey J; Cancer Research Institute, New York, NY, USA., Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Hubbard-Lucey VM; Cancer Research Institute, New York, NY, USA., Ibrahim R; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. rhv@upenn.edu.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA. rhv@upenn.edu.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. rhv@upenn.edu.
Publikováno v:
Nature medicine [Nat Med] 2022 Jun; Vol. 28 (6), pp. 1167-1177. Date of Electronic Publication: 2022 Jun 03.
Autor:
Chan V; Department of Microbiology and Immunology, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA; Department of Pathology, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA; ImmunoX Initiative, Department of Microbiology and Immunology, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA., Gherardini PF; Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, Suite D3500, San Francisco, CA 94129-1504., Krummel MF; Department of Pathology, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA; ImmunoX Initiative, Department of Microbiology and Immunology, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA. Electronic address: matthew.krummel@ucsf.edu., Fragiadakis GK; ImmunoX Initiative, Department of Microbiology and Immunology, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA; UCSF CoLabs, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA; Division of Rheumatology, Department of Medicine, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0511, USA. Electronic address: gabriela.fragiadakis@ucsf.edu.
Publikováno v:
Cell [Cell] 2021 Feb 04; Vol. 184 (3), pp. 566-570.
Autor:
O'Hara MH; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., O'Reilly EM; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Varadhachary G; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA., Wolff RA; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA., Wainberg ZA; Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Ko AH; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Fisher G; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Rahma O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Mick R; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Kitch LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Xu J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Samuel T; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Karakunnel J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Selinsky C; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Till JE; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Carpenter EL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Alanio C; Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Byrne KT; Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chen RO; Personalis, Menlo Park, CA, USA., Trifan OC; Apexigen, San Carlos, CA, USA., Dugan U; Bristol Myers Squibb, New York, NY, USA., Horak C; Bristol Myers Squibb, New York, NY, USA., Hubbard-Lucey VM; Cancer Research Institute, New York, NY, USA., Wherry EJ; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ibrahim R; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Vonderheide RH; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: rhv@upenn.edu.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Jan; Vol. 22 (1), pp. 118-131.
Autor:
Rahil Z; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Leylek R; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Schürch CM; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Chen H; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Bjornson-Hooper Z; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Christensen SR; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Bhate SS; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.; Department of Bioengineering, Stanford University, Stanford, California, USA., Spitzer MH; Department of Microbiology and Immunology and., Fragiadakis GK; UCSF Data Science CoLab and UCSF Department of Medicine, UCSF, San Francisco, California, USA., Mukherjee N; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Kim N; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Jiang S; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Yo J; ARK Clinical Research, Long Beach, California, USA., Gaudilliere B; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA., Affrime M; WCCT Global, Cypress, California, USA., Bock B; WCCT Global, Cypress, California, USA., Hensley SE; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Idoyaga J; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Aghaeepour N; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA., Kim K; ARK Clinical Research, Long Beach, California, USA., Nolan GP; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., McIlwain DR; Department of Pathology and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.; WCCT Global, Cypress, California, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 Nov 02; Vol. 130 (11), pp. 5800-5816.
Autor:
Hartmann FJ; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA., Babdor J; Departments of Otolaryngology-Head and Neck Surgery and Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA., Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94125, USA., Amir ED; Astrolabe Diagnostics, Inc., Fort Lee, NJ 07024, USA., Jones K; Department of Orofacial Sciences, University of California, San Francisco, San Francisco, CA 94143, USA., Sahaf B; Cancer Correlative Science Unit, Cancer Institute, School of Medicine, Stanford University, Palo Alto, CA 94305, USA., Marquez DM; Departments of Otolaryngology-Head and Neck Surgery and Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA., Krutzik P; Primity Bio, Fremont, CA 94538, USA., O'Donnell E; Primity Bio, Fremont, CA 94538, USA., Sigal N; Department of Microbiology and Immunology, Stanford University, Palo Alto, CA 94305, USA., Maecker HT; Department of Microbiology and Immunology, Stanford University, Palo Alto, CA 94305, USA., Meyer E; Cellular Therapy Facility, Blood and Marrow Transplantation, School of Medicine, Stanford University, Palo Alto, CA 94305, USA., Spitzer MH; Departments of Otolaryngology-Head and Neck Surgery and Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94125, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA. Electronic address: matthew.spitzer@ucsf.edu., Bendall SC; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94125, USA. Electronic address: bendall@stanford.edu.
Publikováno v:
Cell reports [Cell Rep] 2019 Jul 16; Vol. 28 (3), pp. 819-831.e4.